Holdings (as at 2025-07-18)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.92%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2025-07-18)
Security Name % of Net Assets
BeOne Medicines Ltd. (ADR) 4.04%
ACADIA Pharmaceuticals Inc. 3.69%
Genmab A/S (ADR) 3.51%
Alnylam Pharmaceuticals, Inc. 3.49%
argenx SE (ADR) 3.46%
Amgen Inc. 3.42%
Krystal Biotech, Inc. 3.41%
Exelixis, Inc. 3.40%
Gilead Sciences, Inc. 3.39%
Halozyme Therapeutics, Inc. 3.39%
Incyte Corporation 3.39%
Neurocrine Biosciences, Inc. 3.39%
United Therapeutics Corporation 3.39%
BioMarin Pharmaceutical Inc. 3.38%
Corcept Therapeutics Inc. 3.38%
Vertex Pharmaceuticals Incorporated 3.36%
Mettler-Toledo International Inc. 3.35%
BioNTech SE (ADR) 3.34%
Exact Sciences Corporation 3.33%
Illumina, Inc. 3.32%
Alkermes Plc 3.31%
Regeneron Pharmaceuticals, Inc. 3.28%
Biogen Inc. 3.19%
Moderna, Inc. 3.19%
Bruker Corporation 3.18%
Repligen Corporation 3.06%
Veracyte, Inc. 2.98%
Natera, Inc. 2.97%
Waters Corporation 2.79%
Sarepta Therapeutics, Inc. 2.66%
Dreyfus Government Cash Management (Institutional Shares) 0.05%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.